Meanwhile, it was demonstrated that the role of HERV-K(HML-2) in cancer immunotherapy had a revealing effect on the anticancer treatment of colorectal cancer patients for the functional enrichment of differential HERV-K(HML-2) loci in the blood of colorectal cancer patients. Here, CLEC10A is linked to colorectal cancer.